Volume 22, Number 5—May 2016
Research
Outbreak of Middle East Respiratory Syndrome at Tertiary Care Hospital, Jeddah, Saudi Arabia, 2014
Table 3
MERS cases potentially acquired at KFGH, Jeddah, Saudi Arabia, March 2–May 10, 2014*
Category | No. (%) cases | Patient median age, y | No. % male patients |
---|---|---|---|
All KFGH-acquired cases |
78 (100.0) |
53 |
59 (75.6) |
Acquisition category | |||
Cohort study case-patient† | 50 (64.1) | 56 | 37 (74.0) |
Healthcare worker at KFGH | 16 (20.5) | 47 | 12 (75.0) |
Visited patient treated at KFGH | 9 (11.5) | 47 | 8 (88.9) |
Outpatient appointment at KFGH | 3 (3.8) | 59 | 2 (66.7) |
*Cases were categorized as potentially KFGH-acquired for persons who had KFGH contact before MERS onset. KFGH, King Fahd General Hospital; MERS, Middle East respiratory syndrome.
†Patients with MERS onset 2‒14 days after emergency department, inpatient, or dialysis treatment at KFGH. Includes 3 healthcare workers (1 who worked at KFGH and 2 at other hospitals) who were admitted to KFGH inpatient areas or emergency department 2‒14 days before MERS onset.
1These authors contributed equally to this article.
2Current affiliation: International Medical Center, Jeddah, Saudi Arabia.
3Current affiliation: Pfizer Inc., Collegeville, Pennsylvania, USA.